Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled Trial

Writing Group for the Women's Health Initiative Investigators·2002·JAMA: The Journal of the American Medical Association
DOI 10.1001/jama.288.3.321

Cited by (1,144)

Items 601–700 of 1,144

  1. Migraine and stroke: a complex association with clinical implications
    Tobias Kurth, Hugues Chabriat, Marie‐Germaine Bousser · 2011 · The Lancet Neurology
  2. The impact of hormones on menopausal sexuality: a literature review
    Gloria Ann Bachmann, Sandra Risa Leiblum · 2004 · Menopause The Journal of The North American Menopause Society
  3. Phytoestrogens derived from red clover: An alternative to estrogen replacement therapy?
    Verena Beck, Uwe D. Rohr, Alois Jungbauer · 2005 · The Journal of Steroid Biochemistry and Molecular Biology
  4. Development of subtype-selective oestrogen receptor-based therapeutics
    Stefan V. Nilsson, Konrad F. Koehler, Jan-Åke Gustafsson · 2011 · Nature Reviews Drug Discovery
  5. Normal, bound and nonbound testosterone levels in normally ageing men: results from the Massachusetts Male Ageing Study
    Beth A. Mohr, André T. Guay, Amy B. O’Donnell, John B. McKinlay · 2004 · Clinical Endocrinology
  6. Risk of Cardiovascular Disease by Hysterectomy Status, With and Without Oophorectomy: The Women’s Health Initiative Observational Study
    Howard, Barbara V., Kuller, Lewis, Langer, Robert, Manson, JoAnn E., Allen, Catherine, Assaf, Annlouise, Cochrane, Barbara B., Larson, Joseph C., Lasser, Norman, Rainford, Monique et al. · 2005 · Circulation
  7. Deep learning predicts hip fracture using confounding patient and healthcare variables
    Badgeley, Marcus A., Zech, John R., Oakden-Rayner, Luke, Glicksberg, Benjamin S., Liu, Manway, Gale, William, McConnell, Michael V., Percha, Bethany, Snyder, Thomas M., Dudley, Joel T. · 2019 · npj Digital Medicine
  8. Ospemifene, a novel selective estrogen receptor modulator for treating dyspareunia associated with postmenopausal vulvar and vaginal atrophy
    David Jay Portman, Gloria Ann Bachmann, James A. Simon · 2013 · Menopause The Journal of The North American Menopause Society
  9. 2011 ACCF/AHA guideline for coronary artery bypass graft surgery: Executive summary
    L. David Hillis, Peter K. Smith, Jeffrey L. Anderson, John A. Bittl, Charles R. Bridges, John G. Byrne, Joaquin E. Cigarroa, Verdi J. DiSesa, Loren F. Hiratzka, Adolph M. Hutter et al. · 2011 · Journal of Thoracic and Cardiovascular Surgery
  10. The Association Between Physical Activity and Osteoporotic Fractures: A Review of the Evidence and Implications for Future Research
    Alireza Moayyeri · 2008 · Annals of Epidemiology
  11. Long-latency deficiency disease: insights from calcium and vitamin D
    Robert P. Heaney · 2003 · American Journal of Clinical Nutrition
  12. Progesterone: Therapeutic opportunities for neuroprotection and myelin repair
    Michaël Schumacher, Rachida Guennoun, Donald G. Stein, Alejandro Federico De Nicola · 2007 · Pharmacology & Therapeutics
  13. Role of estrogen receptor β in colonic epithelium
    Osamu Wada‐Hiraike, Otabek Imamov, Haruko Hiraike, Kjell R. Hultenby, Thomas Schwend, Yoko Omoto, Margaret N. Warner, Jan-Ακε Gustafsson · 2006 · Proceedings of the National Academy of Sciences
  14. Direct antioxidant and protective effect of estradiol on isolated mitochondria
    Consuelo Borrás, Juan Gambini, Raúl López-Grueso, Federico Vicente Pallardó, José Viña · 2009 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
  15. Efficacy of intravaginal dehydroepiandrosterone (DHEA) on moderate to severe dyspareunia and vaginal dryness, symptoms of vulvovaginal atrophy, and of the genitourinary syndrome of menopause
    Fernand Labrie, David F. Archer, William D. Koltun, Andrée Vachon, Douglas G. Young, Louise Frenette, David Jay Portman, Marlene Montesino, Isabelle Côté, Julie Parent et al. · 2016 · Menopause The Journal of The North American Menopause Society
  16. The association between early menopause and risk of ischaemic heart disease: influence of hormone therapy
    Løkkegaard, E., Jovanovic, Z., Heitmann, B.L., Keiding, N., Ottesen, B., Pedersen, A.T. · 2006 · Maturitas
  17. The exciting potential for ChatGPT in obstetrics and gynecology
    Grünebaum, Amos, Chervenak, Joseph, Pollet, Susan L., Katz, Adi, Chervenak, Frank A. · 2023 · American Journal of Obstetrics and Gynecology
  18. Cognitive effects of estradiol after menopause
    Victor W. Henderson, Jan A. St. John, Howard Neil Hodis, Carol A. McCleary, Frank Z. Stanczyk, Donna Shoupe, Naoko Kono, Laurie Labree Dustin, Hooman Allayee, Wendy Jean Mack · 2016 · Neurology
  19. Lack of efficacy of estradiol for depression in postmenopausal women: a randomized, controlled trial
    Mary F. Morrison, Michael J. Kallan, Thomas Ten Have, Ira R. Katz, Kathryn Tweedy, Michelle Battistini · 2003 · Biological Psychiatry
  20. Prophylactic oophorectomy in premenopausal women and long-term health
    Lynne T. Shuster, Bobbie S. Gostout, Brandon R. Grossardt, Walter A. Rocca · 2008 · Menopause international
  21. Overdiagnosis of Invasive Breast Cancer Due to Mammography Screening: Results From the Norwegian Screening Program
    Mette Kalager, Hans‐Olov Adami, Michael Bretthauer, Rulla M. Tamimi · 2012 · Annals of Internal Medicine
  22. Testosterone for peri and postmenopausal women
    Woraluk Somboonporn, Robin J. Bell, Susan R. Davis · 2005 · Cochrane Database of Systematic Reviews
  23. Heart Disease Risk Determines Menopausal Age Rather Than the Reverse
    Helen S. Kok, Kristel M. van Asselt, Yvonne T. van der Schouw, Ingeborg van der Tweel, Petra H. M. Peeters, Peter W.F. Wilson, Peter Lees Pearson, Diederick E. Grobbee · 2006 · Journal of the American College of Cardiology
  24. ASCO/SSO review of current role of risk-reducing surgery in common hereditary cancer syndromes.
    J. Guillem, W. Wood, J. Moley, A. Berchuck, B. Karlan, D. Mutch, R. Gagel, J. Weitzel, M. Morrow, B. Weber et al. · 2006 · Journal of Clinical Oncology
  25. Survival Analysis of Cancer Risk Reduction Strategies for BRCA1/2 Mutation Carriers
    Allison W. Kurian, Bronislava M. Sigal, Sylvia K. Plevritis · 2009 · Journal of Clinical Oncology
  26. Potential Mechanisms of Estrogen Quinone Carcinogenesis
    Judy L. Bolton, Gregory R. J. Thatcher · 2007 · Chemical Research in Toxicology
  27. Tamoxifen for the Prevention of Breast Cancer: Late Results of the Italian Randomized Tamoxifen Prevention Trial Among Women With Hysterectomy
    Umberto Veronesi, Patrick Maisonneuve, Nicole Rotmensz, B. Bonanni, Peter Boyle, Giuseppe Viale, A. Costa, Virgilio Sacchini, Roberto Travaglini, Giuseppe D’Aiuto et al. · 2007 · JNCI Journal of the National Cancer Institute
  28. Bone mineral density in estrogen-deficient young women
    Popat, Vaishali B., Calis, Karim A., Vanderhoof, Vien H., Cizza, Giovanni, Reynolds, James C., Sebring, Nancy, Troendle, James F., Nelson, Lawrence M. · 2009 · The Journal of Clinical Endocrinology & Metabolism
  29. Molecular mechanisms of steroid receptor-mediated actions by synthetic progestins used in HRT and contraception
    Donita Africander, Nicolette J. D. Verhoog, Janet Patricia Hapgood · 2011 · Steroids
  30. Effects of Conjugated Equine Estrogen on Risk of Fractures and BMD in Postmenopausal Women With Hysterectomy: Results From the Women's Health Initiative Randomized Trial
    Rebecca D. Jackson, Jean Wactawski‐Wende, Andrea Z. LaCroix, Mary B. Pettinger, Robert A. Yood, Nelson B. Watts, John A. Robbins, Cora Elizabeth Lewis, Shirley A.A. Beresford, Marcia G. Ko et al. · 2006 · Journal of Bone and Mineral Research
  31. Gender differences in colorectal cancer: implications for age at initiation of screening
    Hermann Brenner, Michael Hoffmeister, Volker Arndt, Ulrike Haug · 2007 · British Journal of Cancer
  32. Quality-of-Life Effects of Prophylactic Salpingo-Oophorectomy Versus Gynecologic Screening Among Women at Increased Risk of Hereditary Ovarian Cancer
    Joanna B. Madalinska, Judith Hollenstein, Eveline M. A. Bleiker, Marc van Beurden, Heiddis Bjork Valdimarsdottir, Leon F.A.G. Massuger, Katja N. Gaarenstroom, Marian J.E. Mourits, René H.M. Verheijen, E.B.L. van Dorst et al. · 2005 · Journal of Clinical Oncology
  33. Vascular consequences of menopause and hormone therapy: Importance of timing of treatment and type of estrogen
    Raghvendra Krishna Dubey, Bruno Imthurn, Matthias Barton, Edwin Kerry Jackson · 2005 · Cardiovascular Research
  34. Menopause—Biology, consequences, supportive care, and therapeutic options
    Susan R. Davis, JoAnn V. Pinkerton, Nanette F. Santoro, Tommaso Simoncini · 2023 · Cell
  35. COX-2 Inhibitors — Lessons in Drug Safety
    Bruce M. Psaty, Curt Daniel Furberg · 2005 · New England Journal of Medicine
  36. Effect of creatine supplementation during resistance training on lean tissue mass and muscular strength in older adults: a meta-analysis
    Chilibeck, Philip, Kaviani, Mojtaba, Candow, Darren, Zello, Gordon A · 2017 · Open Access Journal of Sports Medicine
  37. Pregnancy and Breast Cancer: when They Collide
    Traci Renae Lyons, Pepper J. Schedin, Virginia F. Borges · 2009 · Journal of Mammary Gland Biology and Neoplasia
  38. Venous Thromboembolic Disease
    Michael Blake Streiff, Paula L. Bockenstedt, Spero R. Cataland, Carolyn M. Chesney, Charles Eby, John R. Fanikos, Patrick F Fogarty, Shuwei Gao, Julio García‐Aguilar, Samuel Zachary Goldhaber et al. · 2011 · Journal of the National Comprehensive Cancer Network
  39. Prior hormone therapy and breast cancer risk in the Women's Health Initiative randomized trial of estrogen plus progestin
    Garnet L. Anderson, Rowan T. Chlebowski, Jacques E. Rossouw, Rebecca J. Rodabough, Anne McTiernan, Karen L. Margolis, Anita Aggerwal, J. David Curb, Susan L. Hendrix, F. Allan Hubbell et al. · 2006 · Maturitas
  40. Wnt signaling as a therapeutic target for bone diseases
    Luke H. Hoeppner, Frank J. Secreto, Jennifer J. Westendorf · 2009 · Expert Opinion on Therapeutic Targets
  41. Sex and gender differences in chronic kidney disease: progression to end-stage renal disease and haemodialysis
    Gabriela Cobo, Manfred Hecking, Friedrich K. Port, Isabella Exner, Bengt Lindholm, Peter Stenvinkel, Juan Jesús Carrero · 2016 · Clinical Science
  42. Effects of cardiorespiratory fitness and cerebral blood flow on cognitive outcomes in older women
    Allison D. Brown, Carly A. McMorris, Richard Stewart Longman, Richard Leigh, Michael D. Hill, Christine M. Friedenreich, Marc J. Poulin · 2008 · Neurobiology of Aging
  43. Randomized Double-Blind Trial of Estrogen Replacement Therapy Versus Placebo in Stage I or II Endometrial Cancer: A Gynecologic Oncology Group Study
    Richard R. Barakat, Brian N. Bundy, Nick M. Spirtos, Jeffrey Bell, Robert S. Mannel · 2006 · Journal of Clinical Oncology
  44. Effects of Ultralow-Dose Transdermal Estradiol on Bone Mineral Density: A Randomized Clinical Trial
    Bruce B. Ettinger, Kristine E. Ensrud, Robert B. Wallace, Karen Johnson, Steven Ron Cummings, Vladimir Yankov, Eric Vittinghoff, Deborah G. Grady · 2004 · Obstetrics and Gynecology
  45. 2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease: Executive Summary
    Stephan D. Fihn, Julius M. Gardin, Jonathan Abrams, Kathleen Berra, James C. Blankenship, Apostolos P. Dallas, Pamela S. Douglas, JoAnne Micale Foody, Thomas C. Gerber, Alan L. Hinderliter et al. · 2012 · Journal of the American College of Cardiology
  46. Metabolic and Non-Cognitive Manifestations of Alzheimer’s Disease: The Hypothalamus as Both Culprit and Target of Pathology
    Makoto Ishii, Costantino Iadecola · 2015 · Cell Metabolism
  47. A Sustained Decline in Postmenopausal Hormone Use
    Brian L. Sprague, Amy Trentham‐Dietz, Kathleen A. Cronin · 2012 · Obstetrics and Gynecology
  48. Testosterone and Visceral Fat in Midlife Women: The Study of Women's Health Across the Nation (SWAN) Fat Patterning Study
    İmke Janssen, Lynda H. Powell, Rasa Kazlauskaite, Sheila Ann Dugan · 2009 · Obesity
  49. Ospemifene effectively treats vulvovaginal atrophy in postmenopausal women
    Gloria Ann Bachmann, Janne Komi · 2010 · Menopause The Journal of The North American Menopause Society
  50. VITamins And Lifestyle Cohort Study: Study Design and Characteristics of Supplement Users
    Emily White · 2003 · American Journal of Epidemiology
  51. Water contamination by endocrine disruptors: Impacts, microbiological aspects and trends for environmental protection
    Caren L. S. Vilela, João Paulo Bassin, Raquel Silva Peixoto · 2018 · Environmental Pollution
  52. Efficacy of tissue-selective estrogen complex of bazedoxifene/conjugated estrogens for osteoporosis prevention in at-risk postmenopausal women
    Lindsay, Robert, Gallagher, J. Christopher, Kagan, Risa, Pickar, James H., Constantine, Ginger · 2009 · Fertility and Sterility
  53. Local synthesis and dual actions of progesterone in the nervous system: neuroprotection and myelination
    Michaël Schumacher, Rachida Guennoun, Françoise Robert, C Carelli, Nathalie Gago, Abdel Moumen Ghoumari, Marı́a Claudia González Deniselle, Susana Laura González, Chrystelle Ibanez, Florencia Labombarda et al. · 2004 · Growth Hormone & IGF Research
  54. Remodeling of the Mammary Microenvironment after Lactation Promotes Breast Tumor Cell Metastasis
    Shauntae M. McDaniel, Kristen K. Rumer, Sandra Lyn Biroc, Richard P. Metz, Meenakshi Singh, Weston W. Porter, Pepper S. Schedin · 2006 · American Journal Of Pathology
  55. Benefits and Risks of Postmenopausal Hormone Therapy When It Is Initiated Soon After Menopause
    Ross L. Prentice, JoAnn E. Manson, Robert D. Langer, Garnet L. Anderson, Mary B. Pettinger, Rebecca D. Jackson, Karen Johnson, Lewis H. Kuller, Dorothy S. Lane, Jean Wactawski‐Wende et al. · 2009 · American Journal of Epidemiology
  56. Menopause and women’s cardiovascular health: is it really an obvious relationship?
    Kamila Ryczkowska, Weronika Adach, Kamil Janikowski, Maciej Banach, Agata Magdalena Bielecka-Dabrowa · 2022 · Archives of Medical Science
  57. Risk Factors for a First-Incident Radiographic Vertebral Fracture in Women 65 Years of Age: The Study of Osteoporotic Fractures
    Michael C. Nevitt, Steven Ron Cummings, Katie L. Stone, Lisa Palermo, Dennis M. Black, Douglas C. Bauer, Harry K. Genant, Marc C. Hochberg, Kristine E. Ensrud, Teresa A. Hillier et al. · 2005 · Journal of Bone and Mineral Research
  58. Osteoporosis: Mechanism, Molecular Target and Current Status on Drug Development
    Li, Hanxuan, Xiao, Zhousheng, Quarles, L. Darryl, Li, Wei · 2021 · Current Medicinal Chemistry
  59. Differential neuroprotective and antiinflammatory effects of estrogen receptor (ER) α and ERβ ligand treatment
    Tiwari-Woodruff, Seema, Morales, Laurie Beth J., Lee, Ruri, Voskuhl, Rhonda R. · 2007 · Proceedings of the National Academy of Sciences
  60. Epidemiology of Stroke
    Philip A. Wolf · 2004 · Elsevier eBooks
  61. Estrogen Receptors and Endothelium
    Jean‐François Arnal, Coralie Fontaine, Audrey Billon-Galés, Julie Favre, Henrik Laurell, Françoise Lenfant, Pierre Gourdy · 2010 · Arteriosclerosis Thrombosis and Vascular Biology
  62. Outcome-wide Epidemiology
    Tyler J. VanderWeele · 2017 · Epidemiology
  63. Update on Osteoporosis Screening and Management
    Anika K. Anam, Karl Leonard Insogna · 2021 · Medical Clinics of North America
  64. Randomized Trials of Vitamin E in the Treatment and Prevention of Cardiovascular Disease
    Rachel S. Eidelman, Danielle Hollar, Patricia R. Hebert, Gervasio A. Lamas, Charles H. Hennekens · 2004 · Archives of Internal Medicine
  65. Coxsackievirus B3 Replication and Pathogenesis
    Farshid S. Garmaroudi, David Marchant, Reid G. Hendry, Honglin Luo, Decheng Yang, Xin Ye, Junyan Shi, Bruce M. McManus · 2015 · Future Microbiology
  66. Progesterone Receptor Signaling Mechanisms
    Sandra L. Grimm, Sean Michael Hartig, Dean P. Edwards · 2016 · Journal of Molecular Biology
  67. Psychosocial factors and public health: a suitable case for treatment?
    John Macleod, George Davey Smith · 2003 · Journal of Epidemiology & Community Health
  68. β-Adrenergic Blockers Reduce the Risk of Fracture Partly by Increasing Bone Mineral Density: Geelong Osteoporosis Study
    Pasco, Julie A, Henry, Margaret J, Sanders, Kerrie M, Kotowicz, Mark A, Seeman, Ego, Nicholson, Geoffrey C · 2004 · Journal of Bone and Mineral Research
  69. Age at Natural Menopause and Risk of Ischemic Stroke
    Lynda D. Lisabeth, Alexa Beiser, Devin L. Brown, Joanne M. Murabito, Margaret Kelly‐Hayes, Philip A. Wolf · 2009 · Stroke
  70. Insulin Resistance in Alzheimer's Disease
    Laís S. S. Ferreira, Caroline Fernandes, Marcelo N. N. Vieira, Fernanda G. De Felice · 2018 · Frontiers in Neuroscience
  71. Ovarian cancer
    Nicoletta Colombo, Toon Van Gorp, Gabriella Parma, Frédéric C. Amant, Gemma Gatta, Cristiana Sessa, Ignace B. Vergote · 2006 · Critical Reviews in Oncology/Hematology
  72. Estradiol and Selective Estrogen Receptor Modulators Differentially Regulate Target Genes with Estrogen Receptors α and β
    Meng Kian Tee, Inez Rogatsky, Christina Tzagarakis-Foster, Aleksandra Čvoro, Jinping An, Robert J. Christy, Keith R. Yamamoto, Dale C. Leitman · 2003 · Molecular Biology of the Cell
  73. Estrogen receptors as therapeutic targets in breast cancer.
    Eric A. Ariazi, Jennifer L. Ariazi, F. Cordera, V. Jordan · 2006 · Current Topics in Medicinal Chemistry
  74. Sex differences in micro- and macro-vascular complications of diabetes mellitus
    Maric-Bilkan, Christine · 2017 · Clinical Science
  75. Meta-analysis of cardiovascular disease risk markers in women with polycystic ovary syndrome
    Konstantinos A. Toulis, Dimitrios G. Goulis, Gesthimani Mintziori, Evangelia Kintiraki, Evangelos Eukarpidis, Sophia‐Anastasia Mouratoglou, Antigoni Pavlaki, Stavros Stergianos, Maria Poulasouchidou, Thrasyvoulos Tzellos et al. · 2011 · Human Reproduction Update
  76. Effects of intranasal 17β-estradiol administration on serum bioactive interleukin-6 and C-reactive protein levels in healthy postmenopausal women
    Dominik Rachoń, K Suchecka-Rachoń, Łukasz Hak, Jolanta M. Myśliwska · 2006 · Menopause The Journal of The North American Menopause Society
  77. State of the evidence 2017: an update on the connection between breast cancer and the environment
    Janet Gray, Sharima Rasanayagam, Connie L. Engel, Jeanne Rizzo · 2017 · Environmental Health
  78. Less Is More
    Deborah G. Grady · 2010 · Archives of Internal Medicine
  79. Relation between migraine and stroke
    Marie‐Germaine Bousser, Kenneth M. A. Welch · 2005 · The Lancet Neurology
  80. Sleep Complaints in Community‐Living Older Persons: A Multifactorial Geriatric Syndrome
    Carlos A. Vaz Fragoso, Thomas M. Gill · 2007 · Journal of the American Geriatrics Society
  81. Low Bone Mineral Density in the Hip as a Marker of Advanced Atherosclerosis in Elderly Women
    László B. Tankó, Yu Z. Bagger, Claus Christiansen · 2003 · Calcified Tissue International
  82. The Childhood Adenotonsillectomy Trial (CHAT): Rationale, Design, and Challenges of a Randomized Controlled Trial Evaluating a Standard Surgical Procedure in a Pediatric Population
    Susan S Redline, Raouf Samy Amin, Dean W. Beebe, Ronald David Chervin, Susan L. Garetz, Bruno Giordani, Carole L. Marcus, Reneé H. Moore, CAROL LYNN ROSEN, Raanan Arens et al. · 2011 · SLEEP
  83. Postmenopausal Hypertension
    Matthias Barton, Matthias R. Meyer · 2009 · Hypertension
  84. Long-Term Effects on Cognitive Function of Postmenopausal Hormone Therapy Prescribed to Women Aged 50 to 55 Years
    Mark Andrew Espeland · 2013 · JAMA Internal Medicine
  85. Phytoestrogens for vasomotor menopausal symptoms
    Anne E. Lethaby, Jane Marjoribanks, Fredi Kronenberg, Helen Roberts, John Eden, Julie Brown · 2007 · Cochrane Database of Systematic Reviews
  86. Reprint of Classification and pharmacology of progestins
    Adolf Eduard Schindler, Carlo Campagnoli, René A. Druckmann, Johannes C Huber, Jorge Raul Pasqualini, Karl-Werner Schweppe, J.H.H. Thijssen · 2008 · Maturitas
  87. Stroke in Women: Disparities and Outcomes
    Rebecca Persky, Lisa Christine Turtzo, Louise D. McCullough · 2010 · Current Cardiology Reports
  88. Paroxetine Is an Effective Treatment for Hot Flashes: Results From a Prospective Randomized Clinical Trial
    Vered Stearns, Rebecca S. Slack, Nancy C. Greep, Ronda Henry-Tilman, Michael Osborne, Craig A. Bunnell, Lynda Ullmer, Ann Gallagher, Jennifer C. Cullen, Edmund A. Gehan et al. · 2005 · Journal of Clinical Oncology
  89. The ‘Wise List’– A Comprehensive Concept to Select, Communicate and Achieve Adherence to Recommendations of Essential Drugs in Ambulatory Care in Stockholm
    Lars Lennart Gustafsson, Björn Wettermark, Brian Godman, Eva Karlsson, Ulf Bergman, Jan Hasselström, Lars‐Olof Hensjö, Paul Hjemdahl, Ingrid Jägre, Margaretha Julander et al. · 2011 · Basic & Clinical Pharmacology & Toxicology
  90. Gabapentin, Estrogen, and Placebo for Treating Hot Flushes
    Sireesha Reddy, Hiral Warner, Thomas J. Guttuso, Susan P. Messing, William J. DiGrazio, Loralei Lacina Thornburg, David S. Guzick · 2006 · Obstetrics and Gynecology
  91. The effects of differing resistance training modes on the preservation of bone mineral density in postmenopausal women: a meta-analysis
    Renqing Zhao, M. Zhao, Zijun Xu · 2015 · Osteoporosis International
  92. Guidelines on Urinary Incontinence
    Francisco Cruz, Andrea Tubaro · 2015
  93. Botanicals and Their Bioactive Phytochemicals for Women’s Health
    Birgit M. Dietz, Atieh Hajirahimkhan, Tareisha L. Dunlap, Judy L. Bolton · 2016 · Pharmacological Reviews
  94. Sex-specific relevance of diabetes to occlusive vascular and other mortality: a collaborative meta-analysis of individual data from 980 793 adults from 68 prospective studies
    Louisa Gnatiuc, William Guy Herrington, Jim Halsey, Jaakko Tuomilehto, Xuexian Fang, HC Kim, Dirk De Bacquer, Annette Jane Dobson, Michael H. Criqui, David R. Jacobs et al. · 2018 · The Lancet Diabetes & Endocrinology
  95. Neuroprotective effects of estrogens following ischemic stroke
    Shotaro Suzuki, Candice M. Brown, Phyllis M. Wise · 2009 · Frontiers in Neuroendocrinology
  96. Biology of estrogens in skin: implications for skin aging
    Sylvie Verdier‐Sévrain, Frédéric Bonté, Barbara A. Gilchrest · 2005 · Experimental Dermatology
  97. Estrogen Inhibits Vascular Calcification via Vascular RANKL System
    Mariana Kiomy Osako, Hironori Nakagami A, Nobutaka Koibuchi, Hideo Shimizu, Futoshi Nakagami, Hiroshi Koriyama, Munehisa Shimamura, Takashi Miyake, Hiromi Rakugi, Ryuichi Morishita · 2010 · Circulation Research
  98. Estrogen receptor beta mediates gender differences in ischemia/reperfusion injury
    Scott A. Gabel, V WALKER, R.E. London, Charles Steenbergen, Kenneth Steven Korach, Elizabeth Murphy · 2005 · Journal of Molecular and Cellular Cardiology
  99. The Estrogen Receptors: An Overview from Different Perspectives
    Kathleen M. Eyster · 2015 · Methods in molecular biology
  100. The discovery and mechanism of action of letrozole
    Ajay S. Bhatnagar · 2007 · Breast Cancer Research and Treatment